{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T22:11:43Z","timestamp":1788300703352,"version":"build-2803163510"},"reference-count":44,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2019,2,28]],"date-time":"2019-02-28T00:00:00Z","timestamp":1551312000000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Autonomous Patrimony"},{"name":"National Financing Fund for Science, Technology"},{"name":"Innovation Francisco Jos\u00e9 de Caldas"},{"DOI":"10.13039\/100007637","name":"COLCIENCIAS","doi-asserted-by":"publisher","award":["RC-687\u20132014"],"award-info":[{"award-number":["RC-687\u20132014"]}],"id":[{"id":"10.13039\/100007637","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009087","name":"Industrial University of Santander","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009087","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,6,1]]},"DOI":"10.1093\/jac\/dkz049","type":"journal-article","created":{"date-parts":[[2019,1,18]],"date-time":"2019-01-18T15:15:19Z","timestamp":1547824519000},"page":"1634-1641","source":"Crossref","is-referenced-by-count":28,"title":["Anti-leishmanial activity of a topical miltefosine gel in experimental models of New World cutaneous leishmaniasis"],"prefix":"10.1093","volume":"74","author":[{"given":"Laura Fernanda","family":"Neira","sequence":"first","affiliation":[{"name":"Centro de Investigaci\u00f3n en Enfermedades Tropicales (CINTROP-UIS), Departamento de Ciencias B\u00e1sicas, Escuela de Medicina, Universidad Industrial de Santander, Bucaramanga, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio Cesar","family":"Mantilla","sequence":"additional","affiliation":[{"name":"PAT-UIS, Departamento de Patolog\u00eda, Escuela de Medicina, Universidad Industrial de Santander, Bucaramanga, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Escobar","sequence":"additional","affiliation":[{"name":"Centro de Investigaci\u00f3n en Enfermedades Tropicales (CINTROP-UIS), Departamento de Ciencias B\u00e1sicas, Escuela de Medicina, Universidad Industrial de Santander, Bucaramanga, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,2,27]]},"reference":[{"key":"2019051708104255900_dkz049-B1","volume-title":"Leishmaniasis: Epidemiological Report of the Americas","year":"2018"},{"key":"2019051708104255900_dkz049-B2","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/273595a0","article-title":"Epidemiology and ecology of leishmaniasis in Latin-America","volume":"273","author":"Lainson","year":"1978","journal-title":"Nature"},{"key":"2019051708104255900_dkz049-B3","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1586\/eri.10.19","article-title":"Current diagnosis and treatment of cutaneous and mucocutaneous leishmaniasis","volume":"8","author":"Goto","year":"2010","journal-title":"Expert Rev Anti Infect Ther"},{"key":"2019051708104255900_dkz049-B4","doi-asserted-by":"crossref","first-page":"e0149697.","DOI":"10.1371\/journal.pone.0149697","article-title":"The cure rate after placebo or no therapy in American cutaneous leishmaniasis: a systematic review and meta-analysis","volume":"11","author":"Cota","year":"2016","journal-title":"PLoS One"},{"key":"2019051708104255900_dkz049-B5","doi-asserted-by":"crossref","first-page":"e0005739.","DOI":"10.1371\/journal.pntd.0005739","article-title":"A new perspective on cutaneous leishmaniasis\u2014implications for global prevalence and burden of disease estimates","volume":"11","author":"Bailey","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"2019051708104255900_dkz049-B6","volume-title":"Control of the Leishmaniases. Report of a Meeting of the WHO Expert Committee on the Control of Leishmaniases, Geneva, 22\u201326","year":"2010"},{"key":"2019051708104255900_dkz049-B7","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s40257-015-0114-z","article-title":"Cutaneous leishmaniasis: recent developments in diagnosis and management","volume":"16","author":"de Vries","year":"2015","journal-title":"Am J Clin Dermatol"},{"key":"2019051708104255900_dkz049-B8","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(18)31204-2","article-title":"Leishmaniasis","volume":"392","author":"Burza","year":"2018","journal-title":"Lancet"},{"key":"2019051708104255900_dkz049-B9","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1093\/cid\/cit049","article-title":"Intralesional antimony for single lesions of Bolivian cutaneous leishmaniasis","volume":"56","author":"Soto","year":"2013","journal-title":"Clin Infect Dis"},{"key":"2019051708104255900_dkz049-B10","doi-asserted-by":"crossref","first-page":"58.","DOI":"10.1186\/1745-6215-13-58","article-title":"Thermotherapy. An alternative for the treatment of American cutaneous leishmaniasis","volume":"13","author":"L\u00f3pez","year":"2012","journal-title":"Trials"},{"key":"2019051708104255900_dkz049-B11","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/0035-9203(94)90517-7","article-title":"Topical treatment of American cutaneous leishmaniasis with paromomycin and methylbenzethonium chloride: a clinical study under field conditions in Ecuador","volume":"88","author":"Krause","year":"1994","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"2019051708104255900_dkz049-B12","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.inhe.2012.06.004","article-title":"Local or systemic treatment for New World cutaneous leishmaniasis? Re-evaluating the evidence for the risk of mucosal leishmaniasis","volume":"4","author":"Blum","year":"2012","journal-title":"Int Health"},{"key":"2019051708104255900_dkz049-B13","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1093\/jac\/38.6.1041","article-title":"The activities of four anticancer alkyllysophospholipids against Leishmania donovani, Trypanosoma cruzi and Trypanosoma brucei","volume":"38","author":"Croft","year":"1996","journal-title":"J Antimicrob Chemother"},{"key":"2019051708104255900_dkz049-B14","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0163-7258(95)00001-W","article-title":"Analogs of alkyllysophospholipids: chemistry, effects on the molecular level and their consequences for normal and malignant cells","volume":"66","author":"Brachwitz","year":"1995","journal-title":"Pharmacol Ther"},{"key":"2019051708104255900_dkz049-B15","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1093\/jac\/dks275","article-title":"Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis","volume":"67","author":"Dorlo","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"2019051708104255900_dkz049-B16","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/00001813-200302000-00011","article-title":"Anti-cancer alkyl lysophospholipids inhibit the phosphatidylinositol 3-kinase-Akt\/PKB survival pathway","volume":"14","author":"Ruiter","year":"2003","journal-title":"Anticancer Drugs"},{"key":"2019051708104255900_dkz049-B17","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ijpddr.2013.11.002","article-title":"Untargeted metabolomic analysis of miltefosine action in Leishmania infantum reveals changes to the internal lipid metabolism","volume":"4","author":"Vincent","year":"2013","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"2019051708104255900_dkz049-B18","doi-asserted-by":"crossref","first-page":"e000709.","DOI":"10.1136\/bmjgh-2018-000709","article-title":"Why miltefosine\u2014a life-saving drug for leishmaniasis\u2014is unavailable to people who need it the most","volume":"3","author":"Sunyoto","year":"2018","journal-title":"BMJ Glob Health"},{"key":"2019051708104255900_dkz049-B19","doi-asserted-by":"crossref","first-page":"207","DOI":"10.7705\/biomedica.v26i1.1514","article-title":"Oral miltefosine to treat leishmaniasis","volume":"26","author":"Soto","year":"2006","journal-title":"Biomedica"},{"key":"2019051708104255900_dkz049-B20","doi-asserted-by":"crossref","first-page":"351","DOI":"10.4269\/ajtmh.2010.10-0060","article-title":"Efficacy of miltefosine for the treatment of American cutaneous leishmaniasis","volume":"83","author":"V\u00e9lez","year":"2010","journal-title":"Am J Trop Med Hyg"},{"key":"2019051708104255900_dkz049-B21","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1093\/infdis\/jir816","article-title":"Noninferiority of miltefosine versus meglumine antimoniate for cutaneous leishmaniasis in children","volume":"205","author":"Rubiano","year":"2012","journal-title":"J Infect Dis"},{"key":"2019051708104255900_dkz049-B22","doi-asserted-by":"crossref","first-page":"e02198","DOI":"10.1128\/AAC.02198-16","article-title":"Pharmacokinetics of miltefosine in children and adults with cutaneous leishmaniasis","volume":"61","author":"Castro","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"2019051708104255900_dkz049-B23","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0035-9203(99)90192-X","article-title":"Topical treatment with hexadecylphosphocholine (Miltex) efficiently reduces parasite burden in experimental cutaneous leishmaniasis","volume":"93","author":"Schmidt-Ott","year":"1999","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"2019051708104255900_dkz049-B24","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1111\/jphp.12548","article-title":"Topical formulations of miltefosine for cutaneous leishmaniasis in a BALB\/c mouse model","volume":"68","author":"Van Bocxlaer","year":"2016","journal-title":"J Pharm Pharmacol"},{"key":"2019051708104255900_dkz049-B25","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.3109\/03639045.2016.1141931","article-title":"Development, optimization, and characterization of a novel tea tree oil nanogel using response surface methodology","volume":"42","author":"Sinha","year":"2016","journal-title":"Drug Dev Ind Pharm"},{"key":"2019051708104255900_dkz049-B26","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1208\/s12249-009-9233-2","article-title":"Microemulsion-based vaginal gel of clotrimazole: formulation, in vitro evaluation, and stability studies","volume":"10","author":"Bachhav","year":"2009","journal-title":"AAPS PharmSciTech"},{"key":"2019051708104255900_dkz049-B27","doi-asserted-by":"crossref","first-page":"4681","DOI":"10.3390\/molecules19044681","article-title":"In vitro antioxidant activities, free radical scavenging capacity, and tyrosinase inhibitory of flavonoid compounds and ferulic acid from Spiranthes sinensis (Pers.) Ames","volume":"19","author":"Liang","year":"2014","journal-title":"Molecules"},{"key":"2019051708104255900_dkz049-B28","year":"2015"},{"key":"2019051708104255900_dkz049-B29","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1600-0536.1994.tb00650.x","article-title":"Optimization of the mouse ear swelling test for in vivo and in vitro studies of weak contact sensitizers","volume":"30","author":"Garrigue","year":"1994","journal-title":"Contact Dermatitis"},{"key":"2019051708104255900_dkz049-B30","first-page":"68","article-title":"Toxicidad, genotoxicidad y actividad anti-Leishmania de aceites esenciales obtenidos de cuatro (4) quimiotipos del g\u00e9nero Lippia","volume":"17","author":"Neira","year":"2018","journal-title":"Bol Latinoam Caribe Plant Med Aromat"},{"key":"2019051708104255900_dkz049-B31","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.3390\/nano5042054","article-title":"Composites of polymer hydrogels and nanoparticulate systems for biomedical and pharmaceutical applications","volume":"5","author":"Zhao","year":"2015","journal-title":"Nanomaterials (Basel)"},{"key":"2019051708104255900_dkz049-B32","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3810\/psm.2011.09.1923","article-title":"Dimethyl sulfoxide: an effective penetration enhancer for topical administration of NSAIDs","volume":"39","author":"Marren","year":"2011","journal-title":"Phys Sportsmed"},{"key":"2019051708104255900_dkz049-B33","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.imbio.2013.11.003","article-title":"Dimethyl sulfoxide inhibits NLRP3 inflammasome activation","volume":"219","author":"Ahn","year":"2014","journal-title":"Immunobiology"},{"key":"2019051708104255900_dkz049-B34","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1128\/AAC.26.5.745","article-title":"Development of topical treatment for cutaneous leishmaniasis caused by Leishmania major in experimental animals","volume":"26","author":"El-On","year":"1984","journal-title":"Antimicrob Agents Chemother"},{"key":"2019051708104255900_dkz049-B35","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2340\/00015555-1531","article-title":"Skin pH: from basic science to basic skin care","volume":"93","author":"Ali","year":"2013","journal-title":"Acta Derm Venereol"},{"key":"2019051708104255900_dkz049-B36","doi-asserted-by":"crossref","first-page":"83","DOI":"10.4103\/0975-1483.80290","article-title":"Formulation, in vitro and in vivo pharmacokinetics of anti-HIV vaginal bioadhesive gel","volume":"3","author":"Chatterjee","year":"2011","journal-title":"J Young Pharm"},{"key":"2019051708104255900_dkz049-B37","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1007\/BF01225687","article-title":"Alkylphosphocholine-induced production of nitric oxide and tumor necrosis factor alpha by U 937 cells","volume":"121","author":"Eue","year":"1995","journal-title":"J Cancer Res Clin Oncol"},{"key":"2019051708104255900_dkz049-B38","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1124\/jpet.113.212654","article-title":"Repurposing miltefosine for the treatment of immune-mediated disease?","volume":"350","author":"Verhaar","year":"2014","journal-title":"J Pharmacol Exp Ther"},{"key":"2019051708104255900_dkz049-B39","doi-asserted-by":"crossref","first-page":"e0148084.","DOI":"10.1371\/journal.pone.0148084","article-title":"The role of nitric oxide and reactive oxygen species in the killing of Leishmania braziliensis by monocytes from patients with cutaneous leishmaniasis","volume":"11","author":"Carneiro","year":"2016","journal-title":"PLoS One"},{"key":"2019051708104255900_dkz049-B40","doi-asserted-by":"crossref","first-page":"196","DOI":"10.4049\/jimmunol.1700899","article-title":"NOX2-derived reactive oxygen species control inflammation during Leishmania amazonensis infection by mediating infection-induced neutrophil apoptosis","volume":"200","author":"Carneiro","year":"2018","journal-title":"J Immunol"},{"key":"2019051708104255900_dkz049-B41","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1093\/infdis\/jiu013","article-title":"Human classical monocytes control the intracellular stage of Leishmania braziliensis by reactive oxygen species","volume":"209","author":"Novais","year":"2014","journal-title":"J Infect Dis"},{"key":"2019051708104255900_dkz049-B42","doi-asserted-by":"crossref","first-page":"272","DOI":"10.4269\/ajtmh.2005.73.272","article-title":"The sensitivity of clinical isolates of Leishmania from Peru and Nepal to miltefosine","volume":"73","author":"Yardley","year":"2005","journal-title":"Am J Trop Med Hyg"},{"key":"2019051708104255900_dkz049-B43","doi-asserted-by":"crossref","first-page":"e2871.","DOI":"10.1371\/journal.pntd.0002871","article-title":"Miltefosine and antimonial drug susceptibility of Leishmania Viannia species and populations in regions of high transmission in Colombia","volume":"8","author":"Fern\u00e1ndez","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"2019051708104255900_dkz049-B44","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ijpddr.2018.04.001","article-title":"Comparative efficacy, toxicity and biodistribution of the liposomal amphotericin B formulations Fungisome\u00ae and AmBisome\u00ae in murine cutaneous leishmaniasis","volume":"8","author":"Wijnant","year":"2018","journal-title":"Int J Parasitol Drugs Drug Resist"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/74\/6\/1634\/28666672\/dkz049.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T08:11:52Z","timestamp":1558080712000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/74\/6\/1634\/5366223"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,27]]},"references-count":44,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2019,2,27]]},"published-print":{"date-parts":[[2019,6,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkz049","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,6]]},"published":{"date-parts":[[2019,2,27]]}}}